Work

Presence of Extrachromosomal DNA (ecDNA) Impacts Both Progression Free and Overall Survival and Is an Independent Poor Prognostic Marker in Multiple Myeloma

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-151647

Authors: Parth Shah, Anil Aktas-Samur, Mariateresa Fulciniti, Raphael Szalat, Masood A. Shammas, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, Aurore Perrot, Jill Corre, Philippe Moreau, Anjan Thakurta, Kenneth C. Anderson, Herve Avet-Loiseau, Nikhil C. Munshi, Mehmet K. Samur

Institutions: Dartmouth–Hitchcock Medical Center, Dana-Farber Cancer Institute, Harvard University, Dana-Farber/Harvard Cancer Center, Boston University, Boston Medical Center, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Université de Nantes, Nantes Université, Centre National de la Recherche Scientifique, Inserm, Centre Hospitalier Universitaire de Nantes, Centre Hospitalier Universitaire de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Université de Toulouse, Celgene (United States), Université Toulouse III - Paul Sabatier

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3213259513

Cites:

Cited by:

Related to: 10